首页> 外文期刊>Advances in Infectious Diseases >Rapid Molecular Detection of Tuberculosis and Rifampicine Resistance in Ecuador
【24h】

Rapid Molecular Detection of Tuberculosis and Rifampicine Resistance in Ecuador

机译:快速分子检测厄瓜多尔结核病和利福平抗性

获取原文
           

摘要

>Background: In Ecuador, tuberculosis (TB) remains a serious problem that is complicated by the emergence of multidrug-resistant TB (MDR-TB). To evaluate this problem, this study was carried out at the Social Security Hospital (IESS) in Guayaquil, Ecuador from 2013 to 2015.> Methods: The Xpert TB/RIF system was used to detect TB and MDR-TB and a survey was carried out to identify the factors that are potentially causing MDR-TB. >Findings: 200 TB patients were confirmed on 5649 suspected patients and 20 (10%) with MDR-TB. It was observed that the annual prevalence of TB and MDR-TB had declining during study period. Trends have been declining but co-infection has doubled since 2009 with 16% of patients co-infected with HIV. Potential resistance factors identified were: disruption in drug supply, lack of resources and lack of credibility of treatment.
机译:>背景:在厄瓜多尔,结核病(tb)仍然是多药抗性Tb(MDR-TB)的出现复杂的严重问题。为了评估这一问题,这项研究于2013年至2015年在厄瓜多尔瓜亚基尔的社会保障医院(IESS)进行了这项研究。>方法: Xpert Tb / RIF系统用于检测TB和MDR-进行结核病和调查,以确定可能导致MDR-TB的因素。 >结果: 200TB患者在5649名疑似患者中确认,20例(10%),MDR-TB。观察到,在研究期间,TB和MDR-TB的年度普遍性下降。趋势一直在下降,但自2009年以来,有效期为16%,患者有11%的患者。确定的潜在抵抗因素是:毒品供应中断,缺乏资源和缺乏治疗信誉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号